Alexis Lund
Podiatrist · Hockessin, DENPI 1821453960
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Osteomed LLC at 34.3% of the total. Reporting peaked in 2021 at $1,491 and has fallen 99.7% since, to $4 in 2025.
Across 73 payments — averaging $69.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$2K
- Liberty Surgical Inc.$1K
- Smith+Nephew$1K
- Stryker$565
- Treace Medical Concepts, Inc.$323
- Cardiovascular Systems Inc.$128
- plus $59 from 5 others
What the payments were for
- Travel & lodging$1,07721%
- Food & beverage$2,49549%
- Education$1,53230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 26 | $1,749 |
| Liberty Surgical Inc. | 4 | $1,274 |
| Smith+Nephew | 26 | $1,007 |
| Stryker | 6 | $565 |
| Treace Medical Concepts, Inc. | 5 | $323 |
| Cardiovascular Systems Inc. | 1 | $128 |
| Medtronic | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Aroa Biosurgery Incorporated | 1 | $9 |
| GRT US Holding, Inc. | 1 | $9 |
| Orthofix Medical, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Other$1,032
- PROSTEP MICA$161
- FUSEFORCE$131
- Diamondback Peripheral$128
- GRAFIX PL$121
- Grafix XC$121
- Stravix$121
- STRAVIX PL$121
- SONICANCHOR$114
- Grafix$109
How this compares
$5,104 in reported general payments places this provider in the 75th percentile of 37 podiatrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 19 | $516 |
| Cephalexin | 13 | $324 |
| Meloxicam | 25 | $53 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Hockessin
- Jennifer SeifertNewark$12K
- Harold GruberWilmington$10K
- Lahari MadulapallyWilmington$9K
- Jason KlineNewark$9K
- Matthew WaxmanMiddletown$7K
- Brian McDermottWilmington$7K
- Dimitrios MoustakasSmyrna$7K
- James BrayNewark$7K
- Joseph WendolowskiLewes$5K
- Jessica SommaGeorgetown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.